⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL258995 | 1.00 | — | — | |
| SCHEMBL68935 | 1.00 | — | — | |
| SCHEMBL15058114 | 0.98 | CYP2D6 (0.61) | — | |
| SCHEMBL7998715 | 0.98 | CYP2D6 (0.61) | — | |
| Hydrochloric Acid SCHEMBL10636409 | 0.98 | CYP2D6 (0.61) | — | |
| Hydrochloric Acid SCHEMBL31395319 | 0.98 | CYP2D6 (0.61) | — | |
| SCHEMBL28189436 | 0.98 | CYP2D6 (0.61) | — | |
| Aminolevulinic Acid SCHEMBL2446350 | 0.86 | GABRR1 (0.59) | — | |
| SCHEMBL12019170 | 0.86 | ENPEP (0.52) | — | |
| SCHEMBL11981919 | 0.84 | ENPEP (0.53) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220220155-A1 | VASCULAR CHOLESTEROL INHIBITORS AND USE THEREOF | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (ES) | 2022-07-14 | — | — | US | disclosed |
| US-9840537-B2 | Selective delivery molecules and methods of use | AVELAS BIOSCIENCES, INC. (US) | 2017-12-12 | — | — | US | disclosed |
| US-20170044214-A1 | SELECTIVE DELIVERY MOLECULES AND METHODS OF USE | AVELAS ACQUISITION CORPORATION | 2017-02-16 | — | — | US | disclosed |
| US-20160220707-A1 | SELECTIVE DELIVERY MOLECULES AND METHODS OF USE | AVELAS ACQUISITION CORPORATION | 2016-08-04 | — | — | US | disclosed |
| US-20160152670-A1 | SELECTIVE DELIVERY MOLECULES AND METHODS OF USE | AVELAS ACQUISITION CORPORATION | 2016-06-02 | — | — | US | disclosed |
| US-9278144-B2 | Selective delivery molecules and methods of use | AVELAS BIOSCIENCES, INC. (US) | 2016-03-08 | — | — | US | disclosed |
| WO-2015034920-A2 | GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR COMPOSITIONS | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 2015-03-12 | — | — | WO | disclosed |
| US-20150031852-A1 | SELECTIVE DELIVERY MOLECULES AND METHODS OF USE | AVELAS BIOSCIENCES, INC. (US) | 2015-01-29 | — | — | US | disclosed |
| US-8575094-B2 | Use of type-B lantibiotic-based compounds having antimicrobial activity | NOVACTA BIOSYSTEMS LIMITED (GB) | 2013-11-05 | — | — | US | disclosed |
| US-8357638-B2 | Oligonucleotide library encoding randomised peptides | ASTON UNIVERSITY (GB) | 2013-01-22 | — | — | US | disclosed |
| US-20090264313-A1 | Oligonucleotide library encoding randomised peptides | ASTON UNIVERSITY (GB) | 2009-10-22 | — | — | US | disclosed |
| US-20090203583-A1 | Use of Type-B Lantibiotic-Based Compounds having Antimicrobial Activity | NOVACTA BIOSYSTEMS LIMITED (GB) | 2009-08-13 | — | — | US | disclosed |
| US-7541143-B2 | Homo-doubly labeled compositions for the detection of enzyme activity in biological samples | ONCOIMMUNIN, INC. (US) | 2009-06-02 | — | — | US | disclosed |
| US-20080176821-A1 | LIGANDS FOR METABOTROPIC GLUTAMATE RECEPTORS AND INHIBITORS OF NAALADASE | GEORGETOWN UNIVERSITY | 2008-07-24 | — | — | US | disclosed |
| US-20080103104-A1 | TREATMENT OF CANCER | BIPAR SCIENCES, INC. (US) | 2008-05-01 | — | — | US | disclosed |
| US-20080103208-A1 | INHIBITION OF FATTY ACID SYNTHESIS BY PARP INHIBITORS AND METHODS OF TREATMENT THEREOF | BIPAR SCIENCES, INC. (US) | 2008-05-01 | — | — | US | disclosed |
| US-7307148-B2 | Method for purification of albumin conjugates | CONJUCHEM BIOTECHNOLOGIES INC. (CA) | 2007-12-11 | — | — | US | disclosed |
| US-20070280939-A1 | Prostatic Acid Phosphatase Antigens | NOTTINGHAM TRENT UNIVERSITY, THE (GB) | 2007-12-06 | — | — | US | disclosed |
| US-20070243562-A1 | Lectins for Analyzing Sugar Chains and Method of Using the Same | SUMMIT GLYCORESEARCH CORPORATION (JP) | 2007-10-18 | — | — | US | disclosed |
| US-20070231855-A1 | Functional molecule and manufacturing method therefor | FUJITSU LIMITED (JP) | 2007-10-04 | — | — | US | disclosed |